1. Home
  2. INGN vs CDXS Comparison

INGN vs CDXS Comparison

Compare INGN & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INGN
  • CDXS
  • Stock Information
  • Founded
  • INGN 2001
  • CDXS 2002
  • Country
  • INGN United States
  • CDXS United States
  • Employees
  • INGN N/A
  • CDXS N/A
  • Industry
  • INGN Industrial Specialties
  • CDXS Major Chemicals
  • Sector
  • INGN Health Care
  • CDXS Industrials
  • Exchange
  • INGN Nasdaq
  • CDXS Nasdaq
  • Market Cap
  • INGN 219.3M
  • CDXS 254.3M
  • IPO Year
  • INGN 2014
  • CDXS 2010
  • Fundamental
  • Price
  • INGN $8.36
  • CDXS $2.40
  • Analyst Decision
  • INGN Strong Buy
  • CDXS Buy
  • Analyst Count
  • INGN 3
  • CDXS 2
  • Target Price
  • INGN $11.00
  • CDXS $11.00
  • AVG Volume (30 Days)
  • INGN 244.2K
  • CDXS 1.4M
  • Earning Date
  • INGN 11-06-2025
  • CDXS 10-30-2025
  • Dividend Yield
  • INGN N/A
  • CDXS N/A
  • EPS Growth
  • INGN N/A
  • CDXS N/A
  • EPS
  • INGN N/A
  • CDXS N/A
  • Revenue
  • INGN $343,472,000.00
  • CDXS $57,164,000.00
  • Revenue This Year
  • INGN $7.68
  • CDXS $12.88
  • Revenue Next Year
  • INGN $6.47
  • CDXS $21.64
  • P/E Ratio
  • INGN N/A
  • CDXS N/A
  • Revenue Growth
  • INGN 5.15
  • CDXS N/A
  • 52 Week Low
  • INGN $5.70
  • CDXS $1.90
  • 52 Week High
  • INGN $12.91
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • INGN 68.46
  • CDXS 34.39
  • Support Level
  • INGN $7.72
  • CDXS $2.29
  • Resistance Level
  • INGN $8.18
  • CDXS $2.50
  • Average True Range (ATR)
  • INGN 0.31
  • CDXS 0.15
  • MACD
  • INGN 0.03
  • CDXS -0.05
  • Stochastic Oscillator
  • INGN 96.83
  • CDXS 14.29

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: